Momenta

Developer of novel therapies for rare immune-mediated diseases

placeCambridge, Massachusetts, United States calendar_todayFounded 2001 groups134 employees language momentapharma.com

Registered entities

Investor mix

8 investors on record; lead investors include Atlas Venture, MVM; 2 have since exited.

Investor typeCountShare
Venture capital675%
Private equity225%
Coming soon